Knott David M Jr — 13F Holdings

2026 Q3  ·  92 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, Knott David M Jr maintained a portfolio of 92 distinct positions. The most significant new addition was Oruka Therapeutics, Inc., now representing 0.50% of the total fund value. They heavily accumulated shares in LPL Financial Holdings Inc., increasing the position by 338.0%. Conversely, Knott David M Jr completely exited their position in Catalyst Pharmaceuticals, Inc..
Position History hover any row below to update
Loading…
Knott David M Jr Los Angeles, CA Hedge Fund / Asset Manager AUM $183M
PCA Score Concentration Risk
Risk ENB
Total Positions
92
Quarter
2026 Q3
Top Holding
GOOG (17.0%)
Top 10 Concentration
66.7%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 92

Knott David M Jr Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
GOOG
Alphabet Inc-Cl...
Communication Services 17.04% 17.07% #1
Prev: #1
7.0
—
no change no change
P
S
91,420 $31,150,451 2021 Q4 13F Filing 2026-09-30 2026-11-12
APO
Apollo Global M...
Financial Services 14.28% 14.07% #2
Prev: #2
6.5
—
no change no change
P
S
225,000 $26,113,500 2021 Q4 13F Filing 2026-09-30 2026-11-12
IOVA
Iovance Biother...
Healthcare 9.44% 3.52% #3 5
Prev: #8
4.8
—
-435,000 -27.2%
P
S
1,165,000 $17,265,300 2021 Q4 13F Filing 2026-09-30 2026-11-12
XERS
Xeris Biopharma...
Healthcare 5.24% 4.44% #4
Prev: #4
3.1
—
-57,100 -5.4%
P
S
1,002,900 $9,587,724 2023 Q4 13F Filing 2026-09-30 2026-11-12
SNDX
Syndax Pharmace...
Healthcare 4.40% 5.05% #5 2
Prev: #3
2.8
—
-8,951 -2.0%
P
S
428,294 $8,051,927 2024 Q1 13F Filing 2026-09-30 2026-11-12
TVTX
Travere Therape...
Healthcare 4.19% 4.42% #6 1
Prev: #5
2.2
—
-17,315 -11.8%
P
S
129,967 $7,652,457 2023 Q3 13F Filing 2026-09-30 2026-11-12
BBIO
Bridgebio Pharm...
Healthcare 3.60% 3.66% #7
Prev: #7
3.4
—
7,150 7.7%
P
S
100,000 $6,580,000 2022 Q1 13F Filing 2026-09-30 2026-11-12
JPM
JPMorgan Chase ...
Financial Services 3.15% 3.13% #8 2
Prev: #10
1.8
—
-689 -3.8%
P
S
17,409 $5,759,419 2021 Q4 13F Filing 2026-09-30 2026-11-12
N/A
LPL Financial H...
Unknown 2.76% 2.46% #9 3
Prev: #12
2.1
—
no change no change
P
S
16,500 $5,045,700 — 13F Filing 2026-09-30 2026-11-12
JAAA
Janus Henderson...
ETF 2.58% 2.50% #10 1
Prev: #11
2.0
—
no change no change
P
S
93,528 $4,720,358 2023 Q3 13F Filing 2026-09-30 2026-11-12
ALKS
Alkermes PLC
Healthcare 2.54% 3.37% #11 2
Prev: #9
1.5
—
-7,300 -6.0%
P
S
114,459 $4,637,879 2023 Q2 13F Filing 2026-09-30 2026-11-12
PTGX
Protagonist The...
Healthcare 2.52% 4.08% #12 6
Prev: #6
1.0
—
-30,277 -48.1%
P
S
32,723 $4,610,343 2023 Q3 13F Filing 2026-09-30 2026-11-12
CYBN
Cybin Inc
Unknown 2.49% 1.29% #13 7
Prev: #20
2.0
—
no change no change
P
S
370,000 $4,547,300 2024 Q4 13F Filing 2026-09-30 2026-11-12
COGT
Cogent Bioscien...
Healthcare 2.38% 2.27% #14 1
Prev: #13
3.5
—
25,000 22.5%
P
S
136,081 $4,357,314 2025 Q1 13F Filing 2026-09-30 2026-11-12
VRDN
Viridian Therap...
Healthcare 2.15% 1.76% #15 2
Prev: #17
2.9
—
10,000 5.5%
P
S
191,000 $3,932,690 2024 Q4 13F Filing 2026-09-30 2026-11-12
TGTX
TG Therapeutics...
Healthcare 1.83% 1.94% #16 2
Prev: #14
1.2
—
-7,000 -10.5%
P
S
59,839 $3,337,819 2021 Q4 13F Filing 2026-09-30 2026-11-12
RCUS
Arcus Bioscienc...
Healthcare 1.42% 1.32% #17 2
Prev: #19
3.1
—
19,000 23.4%
P
S
100,241 $2,589,225 2025 Q1 13F Filing 2026-09-30 2026-11-12
MDGL
Madrigal Pharma...
Healthcare 0.99% 0.85% #18 6
Prev: #24
2.9
—
600 20.0%
P
S
3,600 $1,814,256 2022 Q3 13F Filing 2026-09-30 2026-11-12
RLMD
Relmada Therape...
Healthcare 0.99% 1.65% #19 1
Prev: #18
2.4
—
29,000 6.4%
P
S
480,000 $1,809,600 2021 Q4 13F Filing 2026-09-30 2026-11-12
XBI
SPDR S&P Biotec...
ETF 0.95% 1.25% #20 1
Prev: #21
0.4
—
-4,000 -26.7%
P
S
11,000 $1,734,480 2021 Q4 13F Filing 2026-09-30 2026-11-12
AB
AllianceBernste...
Financial Services 0.92% 0.89% #21 2
Prev: #23
1.4
—
no change no change
P
S
48,000 $1,674,240 2021 Q4 13F Filing 2026-09-30 2026-11-12
AGIO
Agios Pharmaceu...
Healthcare 0.89% 1.86% #22 6
Prev: #16
0.4
—
-46,000 -48.4%
P
S
49,058 $1,631,178 2025 Q4 13F Filing 2026-09-30 2026-11-12
OBIO
Orchestra Biome...
Healthcare 0.86% 0.58% #23 10
Prev: #33
1.3
—
no change no change
P
S
253,651 $1,577,709 2025 Q2 13F Filing 2026-09-30 2026-11-12
CGEM
Cullinan Therap...
Healthcare 0.80% 0.67% #24 6
Prev: #30
2.8
—
26,187 37.9%
P
S
95,369 $1,463,914 2026 Q1 13F Filing 2026-09-30 2026-11-12
CDNA
CareDx, Inc.
Healthcare 0.79% 0.21% #25 25
Prev: #50
3.3
—
8,535 62.6%
P
S
22,165 $1,440,725 2026 Q2 13F Filing 2026-09-30 2026-11-12
ELVN
Enliven Therape...
Healthcare 0.72% 0.17% #26 26
Prev: #52
3.3
—
22,721 367.5%
P
S
28,904 $1,324,959 2026 Q2 13F Filing 2026-09-30 2026-11-12
SPRB
Spruce Bioscien...
Healthcare 0.69% 0.57% #27 7
Prev: #34
2.8
—
6,085 30.4%
P
S
26,085 $1,267,209 2026 Q2 13F Filing 2026-09-30 2026-11-12
CLOZ
Eldgridge BBB-B
Unknown 0.69% 0.67% #28 1
Prev: #29
1.3
—
no change no change
P
S
47,807 $1,257,324 2023 Q3 13F Filing 2026-09-30 2026-11-12
DCGO
DocGo, Inc.
Healthcare 0.58% 0.73% #29 3
Prev: #26
1.2
—
no change no change
P
S
2,670,850 $1,067,806 2021 Q4 13F Filing 2026-09-30 2026-11-12
PFE
Pfizer Inc.
Healthcare 0.50% 0.41% #30 8
Prev: #38
1.2
—
no change no change
P
S
32,337 $922,251 2021 Q4 13F Filing 2026-09-30 2026-11-12
ORKA
Oruka Therapeut...
Healthcare 0.50% — #31
Prev: #—
3.7
—
11,000 —
NEW
11,000 $916,190 2026 Q3 13F Filing 2026-09-30 2026-11-12
COLL
Collegium Pharm...
Healthcare 0.47% — #32
Prev: #—
3.7
—
39,000 —
NEW
39,000 $850,980 2024 Q4 13F Filing 2026-09-30 2026-11-12
DYN
Dyne Therapeuti...
Healthcare 0.46% — #33
Prev: #—
3.7
—
52,000 —
NEW
52,000 $837,720 2026 Q3 13F Filing 2026-09-30 2026-11-12
AAPL
Apple Inc.
Technology 0.45% 0.38% #34 5
Prev: #39
1.2
—
no change no change
P
S
2,494 $830,552 2021 Q4 13F Filing 2026-09-30 2026-11-12
MSFT
Microsoft Corpo...
Technology 0.45% 0.32% #35 8
Prev: #43
1.2
—
no change no change
P
S
1,600 $820,640 2021 Q4 13F Filing 2026-09-30 2026-11-12
JNJ
Johnson & Johns...
Healthcare 0.42% 0.66% #36 5
Prev: #31
0.2
—
-2,000 -40.6%
P
S
2,922 $773,570 2021 Q4 13F Filing 2026-09-30 2026-11-12
RZLT
Rezolute, Inc.
Healthcare 0.36% 1.02% #37 15
Prev: #22
0.1
—
-210,362 -56.9%
P
S
159,638 $660,901 2025 Q3 13F Filing 2026-09-30 2026-11-12
CNQ
Canadian Natura...
Energy 0.36% 0.35% #38 2
Prev: #40
0.6
—
-2,882 -17.2%
P
S
13,918 $655,120 2021 Q4 13F Filing 2026-09-30 2026-11-12
LBRX
LB Pharmaceutic...
Healthcare 0.36% 0.22% #39 10
Prev: #49
2.6
—
4,100 31.6%
P
S
17,065 $654,955 2026 Q2 13F Filing 2026-09-30 2026-11-12
IBB
iShares Biotech...
ETF 0.29% 0.55% #40 4
Prev: #36
0.1
—
-3,000 -54.5%
P
S
2,500 $526,325 2025 Q2 13F Filing 2026-09-30 2026-11-12
SLDB
Solid Bioscienc...
Healthcare 0.28% 0.30% #41 5
Prev: #46
2.6
—
14,921 26.5%
P
S
71,129 $514,263 2025 Q1 13F Filing 2026-09-30 2026-11-12
DD
DuPont de Nemou...
Basic Materials 0.27% — #42
Prev: #—
3.6
—
3,767 —
NEW
3,767 $489,296 2021 Q4 13F Filing 2026-09-30 2026-11-12
IBM
International B...
Technology 0.26% 0.32% #43 1
Prev: #42
1.1
—
no change no change
P
S
2,142 $471,090 2023 Q1 13F Filing 2026-09-30 2026-11-12
N/A
Connect Biophar...
Unknown 0.25% 0.56% #44 9
Prev: #35
0.6
—
-24,996 -5.6%
P
S
419,866 $461,853 — 13F Filing 2026-09-30 2026-11-12
BIIB
Biogen Inc.
Healthcare 0.25% 0.46% #45 8
Prev: #37
0.1
—
-2,000 -50.0%
P
S
2,000 $451,760 2025 Q3 13F Filing 2026-09-30 2026-11-12
EWTX
Edgewise Therap...
Healthcare 0.23% — #46
Prev: #—
3.6
—
10,502 —
NEW
10,502 $426,381 2026 Q3 13F Filing 2026-09-30 2026-11-12
PTHS
Pelthos Therape...
Healthcare 0.20% 0.33% #47 6
Prev: #41
0.1
—
-4,429 -20.1%
P
S
17,644 $370,700 2025 Q3 13F Filing 2026-09-30 2026-11-12
NVDA
Nvidia Corp
Technology 0.16% 0.14% #48 8
Prev: #56
1.1
—
no change no change
P
S
1,280 $292,326 2022 Q2 13F Filing 2026-09-30 2026-11-12
RHP
Ryman Hospitali...
Real Estate 0.16% 0.16% #49 4
Prev: #53
1.1
—
no change no change
P
S
2,400 $286,872 2021 Q4 13F Filing 2026-09-30 2026-11-12
INSM
Insmed Incorpor...
Healthcare 0.14% 0.24% #50 2
Prev: #48
0.1
—
-2,000 -47.0%
P
S
2,253 $257,157 2026 Q2 13F Filing 2026-09-30 2026-11-12
Showing 1-50 of 92 holdings

Unlock Full Knott David M Jr Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →